News
Recent news about Panacea Venture and select portfolio companies
Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy
Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry
Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry
Inheritance Patterns of Canavan Disease
Exploring the nuanced landscape of inheritance patterns in Canavan disease when confronted with the identification of only one mutation.
Inheritance Patterns of Canavan Disease
Exploring the nuanced landscape of inheritance patterns in Canavan disease when confronted with the identification of only one mutation.
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
James Huang brings over 30 years of biotech experience as a successful entrepreneur, investor and key opinion leader in the healthcare sector
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
James Huang brings over 30 years of biotech experience as a successful entrepreneur, investor and key opinion leader in the healthcare sector
Exciting Update! Explore Myrtelle’s Insightful Slide Presentation on Gene Therapy for Canavan Disease Preliminary One-Year Results from Meeting on the Mesa.
Here is the link to Alliance for Regenerative Medicine's Youtube Channel. Mark Hurtt gave a presentation last month at Mesa, here is the slideshow he presented with…
Exciting Update! Explore Myrtelle’s Insightful Slide Presentation on Gene Therapy for Canavan Disease Preliminary One-Year Results from Meeting on the Mesa.
Here is the link to Alliance for Regenerative Medicine's Youtube Channel. Mark Hurtt gave a presentation last month at Mesa, here is the slideshow he presented with…